Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Acta Pharmaceutica Sinica B
>
2018
>
8
>
4
Volume:
8
Issue:
4
1. Epigenetic modification in histone deacetylase deletion strain of leads to diverse diterpenoids.
Page:687—697
2. Biocatalytic access to diverse prenylflavonoids by combining a regiospecific -prenyltransferase and a stereospecific chalcone isomerase.
Page:678—686
3. Genome-wide characterization and analysis of bHLH transcription factors in .
Page:666—677
4. monitoring of the structural change of microemulsions in simulated gastrointestinal conditions by SAXS and FRET.
Page:655—665
5. Authentic compound-free strategy for simultaneous determination of primary coumarins in Peucedani Radix using offline high performance liquid chromatography-nuclear magnetic resonance spectroscopy-tandem mass spectrometry.
Page:645—654
6. Limonoids from seeds of A. Juss. and their cytotoxic activity.
Page:639—644
7. Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents.
Page:629—638
8. Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors.
Page:615—628
9. Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer.
Page:602—614
10. Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy.
Page:587—601
11. Garlic-derived compound -allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.
Page:575—586
12. Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 and .
Page:563—574
13. Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy.
Page:552—562
14. The application of CAR-T cell therapy in hematological malignancies: advantages and challenges.
Page:539—551
15. Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective.
Page:530—538
16. Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies.
Page:518—529
17. Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy.
Page:511—517
18. Understanding the biology of HER3 receptor as a therapeutic target in human cancer.
Page:503—510
19. Editorial Preface for Targeted Cancer Therapy.
Page:501—502